Atossa updates corporate presentation on (Z)-Endoxifen programs
Atossa Therapeutics made an updated corporate presentation available highlighting (Z)-Endoxifen clinical progress, regulatory designations and $26.1 million cash.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.